510(k) K201269

Accula Strep A Test by Mesa Biotech, Inc. — Product Code PGX

K201269 is an FDA 510(k) premarket notification submitted by Mesa Biotech, Inc. for the device "Accula Strep A Test". The FDA issued a decision of Substantially Equivalent on Nov 9, 2020. The device falls under product code PGX (Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System), a Class II device regulated under 21 CFR 866.2680. Mesa Biotech, Inc. has 2 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Nov 9, 2020
Date Received
May 12, 2020
Clearance Type
Dual Track
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System
Device Class
Class II
Regulation Number
866.2680
Review Panel
MI
Submission Type
510(k)

An in vitro diagnostic test for the detection of Group A, C and G beta hemolytic Streptococcus in throat swab specimens from symptomatic patients.

Need the full FDA record for Mesa Biotech, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K201269. Report a data issue: hello@regdatalab.com.